Latest 8-K filings

Tyson Foods announces a strategic restructuring of its beef business, including the closure of two facilities and the sale of another, to optimize its network amidst cattle supply shortages.

XBP Global Holdings reported a Q2 2026 with a revenue decline but notable improvements in profitability metrics and strong contract value growth.

BlackSky Technology Inc. received a NYSE notice regarding the commencement of delisting proceedings for its warrants due to abnormally low selling prices.

Net Power recalibrates its strategy to focus on fast-to-deploy, unabated natural gas power generation to meet accelerating demand from AI and data centers, while retaining carbon capture as a future option.

Xylem Inc. announced the appointment of D. Christian Koch to its Board of Directors, expanding the board to ten members and adding significant leadership experience.

CAMP4 Therapeutics announced Q2 2026 results, highlighting regulatory clearance for its CMP-002 Phase 1/2 trial in SYNGAP1 patients and securing $50.1 million in funding, extending cash runway to end of 2028.

GrabAGun Digital Holdings Inc. announces the retirement of CFO Justin Hilty and the appointment of Jonathan Terry, a seasoned finance executive, to lead the company's next growth phase.

Roadzen Inc. announced its strongest first quarter in company history, with revenue soaring 49% year-over-year to $16.2 million, driven by its AI platform adoption and strategic acquisition plans.

Illumina, Inc. has entered into a new $1 billion senior unsecured five-year revolving credit facility, replacing its existing agreement.

Boyd Gaming Corporation announced its Board of Directors has declared a cash dividend of $0.20 per share, payable in October 2026.

Life Time Group Holdings, Inc. has successfully refinanced its $985 million term loan facility, reducing the interest rate margin and lowering its effective fixed interest rate.

TechPrecision Corporation announced robust first-quarter fiscal year 2027 financial results, showcasing a 23% increase in revenue and a 36% rise in gross profit, alongside a significant reduction in net loss.

KULR Technology Group announced its second quarter 2026 financial results, revealing a 43% decrease in revenue and a significant drop in gross margins, alongside an increased operating loss, heavily influenced by cryptocurrency fair value changes.

NextPlat Corp announced a significant financial turnaround for Q2 2026, with a 21% sequential revenue increase, an 87% reduction in net loss to $144,000, and a record gross margin of approximately 40%.

Addus HomeCare Corporation announced the departure of its President and Chief Operating Officer, Heather Dixon, and the interim appointment of W. Bradley Bickham to the COO role.

QXO, Inc. announced its second quarter 2026 financial results, reporting increased net sales to $3.25 billion but a net loss of $55 million, alongside adjusted diluted earnings per share of $0.08.

AmpliTech Group announced Q2 2026 results, featuring an 8.07 million revenue, up 50.9% sequentially, and a 161.2% year-over-year gross profit increase.

Swarmer, Inc. announced its second quarter 2026 financial results, showcasing revenue growth and expanded customer contracts, alongside strategic partnerships aimed at advancing drone autonomy.

Pyxus International, Inc. announced the outcomes of its 2026 annual shareholder meeting, including the election of directors and ratification of auditors.

Cibus, Inc. announced its second quarter financial results, showcasing advancements in its Rice and Sustainable Ingredients programs, favorable regulatory developments in the EU and US, and a sequential decrease in net cash usage.

Yarrow Bioscience, Inc. (now Yarrow Bioscience Operating Company Corp.) announced the completion of its merger with VYNE Therapeutics, securing approximately $200 million in financing and providing an estimated cash runway into 2028, while advancing its lead drug candidate YB-101 for autoimmune thyroid diseases.

Dillard's announced robust second-quarter results, with net income soaring to $97.7 million, driven by significant tariff rebates and a favorable litigation settlement, alongside a 1% increase in total retail sales.

Quantum-Si announced a revised Proteus launch to Q2 2027, impacting its cash runway and leading to a 20% workforce reduction.

T Stamp Inc. announced a 22% increase in net recognized revenue for H1 2026, reaching $1.66 million, and detailed strategic initiatives including participation in the EU's IPCEI program and expansion into the $48 billion Sovereign-AI market.

Assembly Biosciences reported Q2 2026 results, highlighting a $115 million financing, expansion of ABI-6250 into new indications, and progress on the GS-1179 HSV program, with cash runway projected into 2029.

Rani Therapeutics announced second quarter 2026 financial results, highlighting positive initial Phase 1a data for RT-114, a $20 million capital raise, and a new collaboration with PegBio.

Invivyd announced second quarter 2026 financial results, highlighting a 21% increase in PEMGARDA net product revenue to $14.3 million and progress in key clinical trials for VYD2311.

Merlin, Inc. announced second quarter 2026 results, highlighting advancements in autonomous flight technology and strategic partnerships, while ending the quarter with $183.9 million in cash and no debt.

Eledon Pharmaceuticals reported strong Q2 2026 results, with successful FDA meetings for its Phase 3 kidney transplant trial and promising clinical data for tegoprubart.

Ames National Corporation announced the declaration of a cash dividend of $0.24 per common share, payable September 15, 2026.